Old Web
English
Sign In
Acemap
>
Paper
>
Abstract 5080: Inhibiting the ALK1/BMP9 signaling pathway with dalantercept as an antiangiogenic therapy.
Abstract 5080: Inhibiting the ALK1/BMP9 signaling pathway with dalantercept as an antiangiogenic therapy.
2013
Marat Alimzhanov
Nicolas Solban
Michael Lee
Phaethon Philbrook
Xiaoen Wang
Lin Wei
Jiaxi Song
Sabina Signoretti
R. Scott Pearsall
Matthew L. Sherman
Ravindra Kumar
Rupal S. Bhatt
Keywords:
Dalantercept
Cancer research
Signal transduction
Immunology
Medicine
antiangiogenic therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]